Reversing memory deficits and impairments in spatial learning is a major goal in the field of dementia research. A lack of knowledge about cellular pathways critical to the development of dementia, however, has stood in the way of significant clinical advance. But now, researchers at the Lewis Katz School of Medicine at Temple University (LKSOM) are breaking through that barrier. They show, for the first time in an animal model, that tau pathology – the second-most important lesion in the brain in patients with Alzheimer’s disease – can be reversed by a drug.
“We show that we can intervene after disease is established and pharmacologically rescue mice that have tau-induced memory deficits,” explained senior investigator Domenico Praticò, MD, Scott Richards North Star Foundation Chair for Alzheimer’s Research, Professor in the Departments of Pharmacology and Microbiology, and Director of the Alzheimer’s Center at Temple at LKSOM. The study, published online in the journal Molecular Neurobiology, raises new hope for human patients affected by dementia.
The researchers landed on their breakthrough after discovering that inflammatory molecules known as leukotrienes are deregulated in Alzheimer’s disease and related dementias. In experiments in animals, they found that the leukotriene pathway plays an especially important role in the later stages of disease.
“At the onset of dementia, leukotrienes attempt to protect nerve cells, but over the long term, they cause damage,” Dr. Praticò said. “Having discovered this, we wanted to know whether blocking leukotrienes could reverse the damage, whether we could do something to fix memory and learning impairments in mice having already abundant tau pathology.”
To recapitulate the clinical situation of dementia in humans, in which patients are already symptomatic by the time they are diagnosed, Dr. Praticò and colleagues used specially engineered tau transgenic mice, which develop tau pathology – characterized by neurofibrillary tangles, disrupted synapses (the junctions between neurons that allow them to communicate with one another), and declines in memory and learning ability – as they age. When the animals were 12 months old, the equivalent of age 60 in humans, they were treated with zileuton, a drug that inhibits leukotriene formation by blocking the 5-lipoxygenase enzyme.
After 16 weeks of treatment, animals were administered maze tests to assess their working memory and their spatial learning memory. Compared with untreated animals, tau mice that had received zileuton performed significantly better on the tests. Their superior performance suggested a successful reversal of memory deficiency.
To determine why this happened, the researchers first analyzed leukotriene levels. They found that treated tau mice experienced a 90-percent reduction in leukotrienes compared with untreated mice. In addition, levels of phosphorylated and insoluble tau, the form of the protein that is known to directly damage synapses, were 50 percent lower in treated animals. Microscopic examination revealed vast differences in synaptic integrity between the groups of mice. Whereas untreated animals had severe synaptic deterioration, the synapses of treated tau animals were indistinguishable from those of ordinary mice without the disease.
“Inflammation was completely gone from tau mice treated with the drug,” Dr. Praticò said. “The therapy shut down inflammatory processes in the brain, allowing the tau damage to be reversed.”
The study is especially exciting because zileuton is already approved by the Food and Drug Administration for the treatment of asthma. “Leukotrienes are in the lungs and the brain, but we now know that in addition to their functional role in asthma, they also have a functional role in dementia,” Dr. Praticò explained.
“This is an old drug for a new disease,” he added. “The research could soon be translated to the clinic, to human patients with Alzheimer’s disease.”
The Latest on: Dementia
via Google News
The Latest on: Dementia
Police in Indy searching missing 67-year-old with dementia
on August 17, 2018 at 3:53 pm
INDIANAPOLIS -- Police are searching for an endangered adult missing from Indianapolis for more than 24 hours. Indianapolis Metropolitan Police Department officers say 65-year-old Willie Hicks was las... […]
It's not like people forget to name Alzheimer's. Why is Lewy body dementia so anonymous?
on August 17, 2018 at 3:52 pm
This is one of an occasional series of opinion columns on Lewy body dementia, other dementias, and end of life issues written by a writer who happens to have the brain degenerative disease. As I've po... […]
Battling dementia, ‘Star Trek’s’ Lt. Uhura begs her son to attend conventions
on August 17, 2018 at 2:16 pm
Nichelle Nichols, Star Trek’s Lieutenant Uhura, pleads to earn with fans (Image Source: DragonCon Media Relations and Paramount Pictures promotional photo) Actress Nichelle Nichols, best known for her ... […]
IMPD searching for missing 67-year-old man who suffers from dementia
on August 17, 2018 at 1:32 pm
INDIANAPOLIS, Ind.– Police are searching for a missing man who suffers from dementia. Willie Hicks, 67, was last seen around midnight Thursday in the 3500 block of North Butler Avenue, near Emerson Av... […]
Dementia patients may benefit from music therapy
on August 17, 2018 at 10:13 am
(Reuters Health) - Music therapy may improve depression and anxiety in dementia patients, a new analysis suggests. Music therapy might also improve emotional well-being among those with dementia, rese... […]
7 Brain Exercises You Can Do To Prevent Dementia
on August 17, 2018 at 9:15 am
Dementia and Alzheimer’s are diseases nobody wants to get. And it’s very difficult to watch a loved one forget who they are and who you are all because of an incurable disease. Although it’s impossibl... […]
Why some people with brain markers of Alzheimer's have no dementia
on August 17, 2018 at 8:10 am
A new study has uncovered why some people that have brain markers of Alzheimer's disease (AD) never develop the classic dementia that others do. The results showed that resilient individuals had a uni... […]
Why Some People Have Markers for Alzheimer's But No Dementia
on August 17, 2018 at 7:55 am
Researchers at the University of Texas Medical Branch at Galveston have discovered why some people who have brain markers of Alzheimer's don’t develop classic dementia typically associated with the di... […]
Could different cultures teach us something about dementia?
on August 17, 2018 at 7:30 am
Picture two different families, each dealing with a diagnosis of dementia in one of its members. In one case, the patient is a retired executive, whose family tries as long as possible to keep the dia... […]
via Bing News